|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1804463
|
|
Name of medicinal product:
|
Cryptisel
|
|
Active substances:
|
|
|
ATC code:
|
QP51BX01
|
|
Dosage form:
|
oral solution
|
|
Route of administration:
|
oral use
|
|
Strengh:
|
0,5mg 1ml
|
|
Amount in package:
|
490ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Prevention of diarrhoea due to diagnosed Cryptosporidium parvum, in farms with history of cryptosporidiosis.
Administration should start in the first 24 to 48 hours of age.
Reduction of diarrhoea due to diagnosed Cryptosporidium parvum.
Administration should start within 24 hours after the onset of diarrhoea.
In both cases, the reduction of oocysts excretion has been demonstrated.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated March 31, 2023)
|
|
Package information leaflet (PIL):
|
EST (last updated November 2, 2020)
|
|
Labelling:
|
(last updated November 2, 2020)
|
|
Withdrawal time:
|
Lihale ja söödavatele kudedele: 13 päeva.
|
|
Species:
|
veis (vasikas)
|
|
Last imported to Estonia:
|
October 20, 2023
|
|
Marketing authorization holder:
|
Livisto Int'l S.L.
|
|
Marketing authorization number:
|
2258
|
|
Marketing authorization issued on:
|
November 2, 2020
|
|
Marketing authorization expires on:
|
November 2, 2025
|
|
Marketing authorization procedure type:
|
Decentralised
|
Entry/Changing date:
March 31, 2023
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere